BETA-LACTAMASE-HEMMER

Patent europeic · EP2928898 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2928898
Numer da la dumonda
EP13861198
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
05-12-2013
Publitgà
14-10-2015
Concedì
14-04-2021
La protecziun finescha il pli tard
04-12-2033
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61K 31/69 (2006.01)
C07F 5/02 (2006.01)
A61K 45/06 (2006.01)
A61P 31/04 (2006.01)
Prioritad
US 201261734900 P 07.12.2012
US 201361783238 P 14.03.2013
Dumonda PCT
PCT/US2013/073428 05.12.2013
Publicaziun PCT
WO2014/089365 12.06.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 27-05-2026

    Midada

    Published in Swissreg on 27.05.2026

  2. 09-01-2025

    Midada

    Published in Swissreg on 09.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 10-01-2023

    Midada

    Published in Swissreg on 10.01.2023

  5. 23-02-2022

    Midada

    Published in Swissreg on 23.02.2022

  6. 14-04-2021

    Concedì

    Published in Swissreg on 14.04.2021

Partidas

Possessur

Venatorx Pharmaceuticals, Inc.

30 Spring Mill Drive, Malvern, PA 19355, US

Inventur

MCGARRY, Daniel

Exton, PA 19341, US

TROUT, Robert E. Lee

Bechtelsville, PA 19505, US

DAIGLE, Denis

Havre de Grace, MD 21078, US

PEVEAR, Daniel C.

Downingtown, PA 19335, US

LIU, Bin

Dayton, NJ 08810, US

BURNS, Christopher, J.

Malvern, PA 19355, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.